[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (92,833)

Search Parameters:
Keywords = standardize

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
13 pages, 241 KiB  
Review
PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature
by Anusha Agarwal, Chase J. Wehrle, Sangeeta Satish, Paresh Mahajan, Suneel Kamath, Shlomo Koyfman, Wen Wee Ma, Maureen Linganna, Jamak Modaresi Esfeh, Charles Miller, David C. H. Kwon, Andrea Schlegel and Federico Aucejo
Biomedicines 2025, 13(1), 123; https://doi.org/10.3390/biomedicines13010123 (registering DOI) - 7 Jan 2025
Abstract
Solid-organ malignancies represent a significant disease burden and remain one of the leading causes of death globally. In the past few decades, the rapid evolution of imaging modalities has shifted the paradigm towards image-based precision medicine, especially in the care of patients with [...] Read more.
Solid-organ malignancies represent a significant disease burden and remain one of the leading causes of death globally. In the past few decades, the rapid evolution of imaging modalities has shifted the paradigm towards image-based precision medicine, especially in the care of patients with solid-organ malignancies. Metabolic tumor volume (MTV) is one such semi-quantitative parameter obtained from positron emission tomography (PET) imaging with 18F-fluorodeoxyglucose (FDG) that has been shown to have significant implications in the clinical oncology setting. Across various solid tumor malignancies, including lung cancer, head and neck cancer, breast cancer, esophageal cancer, and colorectal cancer, the current literature has demonstrated an association between MTV and various clinical outcomes. MTV may be used in conjunction with several existing and established clinical parameters to help inform risk stratification and treatment strategies and predict outcomes in cancer. Optimizing such volumetric parameters is paramount for advancing efforts to advance cancer care for our patients. While such advancements are made, it is important to investigate and address the limitations of MTV, including variability in terms of measurement methods, a lack of standardized cut-off values, and the impact of inherent tumor heterogeneity. Despite these limitations, which can precipitate challenges in standardization, MTV as a prognostic factor has great potential and opens an avenue for the future integration of technology into an image-based precision medicine model of care for cancer patients. This article serves as a narrative review and explores the utility and limitations of PET-MTV in various settings of solid-organ malignancy. Full article
(This article belongs to the Special Issue Applications of Imaging Technology in Human Diseases)
Show Figures

Graphical abstract

Graphical abstract
Full article ">
17 pages, 2183 KiB  
Article
Effect of Acoustic Absorber Type and Size on Sound Absorption of Porous Materials in a Full-Scale Reverberation Chamber
by Oshoke Wil Ikpekha and Mark Simms
Acoustics 2025, 7(1), 3; https://doi.org/10.3390/acoustics7010003 (registering DOI) - 7 Jan 2025
Abstract
The acoustic product development process, crucial for effective noise control, emphasises efficient testing and validation of materials for sound absorption in the R&D phase. Balancing cost-effectiveness, speed, and sustainability, the focus is on minimising excess materials. While strides have been made in reducing [...] Read more.
The acoustic product development process, crucial for effective noise control, emphasises efficient testing and validation of materials for sound absorption in the R&D phase. Balancing cost-effectiveness, speed, and sustainability, the focus is on minimising excess materials. While strides have been made in reducing sample sizes for estimating random-incident absorption, challenges persist, particularly in establishing validity thresholds for smaller samples with increasing thickness, susceptible to potential overestimation due to edge effects. This study delves into analysing the absorption coefficients of widely used acoustic absorber types—polyester, fibreglass, and open-cell foam—in a full-scale reverberation chamber at Ventac, Blessington, and Wicklow. Demonstrating significant absorption above 500 Hz, these porous absorbers exhibit diminished effectiveness at lower frequencies. The strategic combination of these absorbers with different facings enhances their theoretical broadband absorption characteristics in practical applications. Moreover, the study assesses the validity threshold for reduced sample sizes, employing statistical analysis against ISO 354:2003 standard control samples of the absorber types. Analysis of Variance (ANOVA) on material groups underscores the significant influence of frequency components and sample sizes on the absorption coefficient. The determined validity threshold for 12.8 sqm ISO 354 standard control size is 7.7 sqm for the 25 mm open-cell foam. Similarly, the validity threshold of the 12 sqm ISO 354 standard control size is 9.6 sqm for the 20 mm 800 gsm polyester, 7.2 sqm for the 25 mm fibreglass, and the vinyl black on 25 mm fibreglass. Full article
(This article belongs to the Special Issue Acoustic Materials)
Show Figures

Figure 1

Figure 1
<p>ISO standard control material test Specimens mounted in the reverberation chamber. Sample (<b>A</b>): 20 mm 800 gsm polyester (12 sqm surface area), Sample (<b>B</b>): 25 mm open-cell foam (12.8 sqm surface area), Sample (<b>C</b>): E-cloth on 25 mm fibreglass (12 sqm surface area), Sample (<b>D</b>): perorated and embossed foil on 25 mm fibreglass (12 sqm surface area), Sample (<b>E</b>): fibreglass (12 sqm surface area), and Sample (<b>F</b>): vinyl black on fibreglass (12 sqm surface area).</p>
Full article ">Figure 2
<p>Sample decay curve for 500 Hz frequency.</p>
Full article ">Figure 3
<p>Reverberation chamber showing the microphones and suspended diffusers.</p>
Full article ">Figure 4
<p>Measured sound absorption coefficient for 6 different absorber (specimen) types.</p>
Full article ">Figure 5
<p>Absorption coefficient of 6 different size samples for the six absorber (specimen) types in a full-scale reverberation chamber.</p>
Full article ">Figure 6
<p>Mean absorption coefficient plot of the six specimen types in a full-scale reverberation chamber at six different sizes. For each group of specimen type, means that do not share a letter are significantly different, as depicted by their respective tables’ inset of the graph.</p>
Full article ">
20 pages, 305 KiB  
Article
Derivation of Tensor Algebra as a Fundamental Operation—The Fermi Derivative in a General Metric Affine Space
by Michael Tsamparlis
Symmetry 2025, 17(1), 81; https://doi.org/10.3390/sym17010081 (registering DOI) - 7 Jan 2025
Abstract
The aim of this work is to demonstrate that all linear derivatives of the tensor algebra over a smooth manifold M can be viewed as specific cases of a broader concept—the operation of derivation. This approach reveals the universal role of differentiation, which [...] Read more.
The aim of this work is to demonstrate that all linear derivatives of the tensor algebra over a smooth manifold M can be viewed as specific cases of a broader concept—the operation of derivation. This approach reveals the universal role of differentiation, which simplifies and generalizes the study of tensor derivatives, making it a powerful tool in Differential Geometry and related fields. To perform this, the generic derivative is introduced, which is defined in terms of the quantities Qk(i)(X). Subsequently, the transformation law of these quantities is determined by the requirement that the generic derivative of a tensor is a tensor. The quantities Qk(i)(X) and their transformation law define a specific geometric object on M, and consequently, a geometric structure on M. Using the generic derivative, one defines the tensor fields of torsion and curvature and computes them for all linear derivatives in terms of the quantities Qk(i)(X). The general model is applied to the cases of Lie derivative, covariant derivative, and Fermi derivative. It is shown that the Lie derivative has non-zero torsion and zero curvature due to the Jacobi identity. For the covariant derivative, the standard results follow without any further calculations. Concerning the Fermi derivative, this is defined in a new way, i.e., as a higher-order derivative defined in terms of two derivatives: a given derivative and the Lie derivative. Being linear derivative, it has torsion and curvature tensor. These fields are computed in a general affine space from the corresponding general expressions of the generic derivative. Applications of the above considerations are discussed in a number of cases. Concerning the Lie derivative, it is been shown that the Poisson bracket is in fact a Lie derivative. Concerning the Fermi derivative, two applications are considered: (a) the explicit computation of the Fermi derivative in a general affine space and (b) the consideration of Freedman–Robertson–Walker spacetime endowed with a scalar torsion field, which satisfies the Cosmological Principle and the computation of Fermi derivative of the spatial directions defining a spatial frame along the cosmological fluid of comoving observers. It is found that torsion, even in this highly symmetric case, induces a kinematic rotation of the space axes, questioning the interpretation of torsion as a spin. Finally it is shown that the Lie derivative of the dynamical equations of an autonomous conservative dynamical system is equivalent to the standard Lie symmetry method. Full article
(This article belongs to the Special Issue Advances in Nonlinear Systems and Symmetry/Asymmetry)
19 pages, 1093 KiB  
Article
Retrospective Single-Center Analysis of 5575 Spinal Surgeries for Complication Associations and Potential Future Use of Generated Data
by Yoram Materlik, Volker Martin Tronnier and Matteo Mario Bonsanto
J. Clin. Med. 2025, 14(2), 312; https://doi.org/10.3390/jcm14020312 (registering DOI) - 7 Jan 2025
Abstract
Background: This study aims to retrospectively detect associations with postoperative complications in spinal surgeries during the hospitalization period using standardized, single-center data to validate a method for complication detection and discuss the potential future use of generated data. Methods: Data were [...] Read more.
Background: This study aims to retrospectively detect associations with postoperative complications in spinal surgeries during the hospitalization period using standardized, single-center data to validate a method for complication detection and discuss the potential future use of generated data. Methods: Data were generated in 2006–2019 from a standardized, weekly complications conference reviewing all neurosurgical operations at the University Hospital Luebeck. Paper-based data were recorded in a standardized manner during the conference and transferred with a time delay of one week into a proprietary complication register. A total of 5575 cases were grouped based on the diagnosis, surgical localization, approach, instrumentation, previous operations, surgery indication, age, ASA score, and pre-existing conditions. Retrospective analysis was performed using a logistic regression detecting complication associations. The results were compared to the literature validating the method of complication detection. Results: Mean cohort age: 58.83 years. Overall complication rate: 10.9%. Mortality rate: 0.25%. The statistically significant complication associations were age; an age of >60; the localization (cervical, thoracic); a cervical tumor or trauma diagnosis; lumbar degenerative conditions, tumor, trauma, or infection; a cervical hemi-/laminectomy and vertebral body replacement; a lumbar hemi-/laminectomy, posterior spondylodesis, and 360° fusion; lumbar instrumentation, with an ASA score of three and four; a ventral and combined/360° approach; a lumbar combined/360° revision; two, three and ≥four pre-existing conditions; hypertension; osteoporosis; arrhythmia; an oncological condition; kidney dysfunction; stroke; and thrombosis. Conclusions: Documenting risk profiles for spinal procedures is important in identifying postoperative complications. The available data provide a comprehensive overview within a single center for spinal surgeries. Standardized complication recording during an established complication conference in the clinical routine enables the detection of significant complications. It is desirable to standardize the registration of postoperative complications to facilitate comparability across different institutions. The results may contribute to national or international databases used for automated AI risk profiling. Full article
(This article belongs to the Section Clinical Neurology)
Show Figures

Figure 1

Figure 1
<p>Representation of the data generation process for complication recording in the Department of Neurosurgery at University Hospital Luebeck.</p>
Full article ">Figure 2
<p>Flowchart visualizing the data grouping process.</p>
Full article ">
15 pages, 790 KiB  
Article
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma
by Valeria Guarneri, Elisabetta Loggi, Giuseppe Ramacieri, Carla Serra, Ranka Vukotic, Giovanni Vitale, Alessandra Scuteri, Carmela Cursaro, Marzia Margotti, Silvia Galli, Maria Caracausi, Lucia Brodosi, Filippo Gabrielli and Pietro Andreone
Cancers 2025, 17(2), 167; https://doi.org/10.3390/cancers17020167 (registering DOI) - 7 Jan 2025
Abstract
Background and Aims: Hepatocellular carcinoma (HCC) represents the second leading cause of cancer deaths worldwide. Six-month imaging along with alpha-fetoprotein (AFP) serum levels detection are the current gold standard to exclude HCC. Protein induced by vitamin K absence (PIVKA-II) has been proposed as [...] Read more.
Background and Aims: Hepatocellular carcinoma (HCC) represents the second leading cause of cancer deaths worldwide. Six-month imaging along with alpha-fetoprotein (AFP) serum levels detection are the current gold standard to exclude HCC. Protein induced by vitamin K absence (PIVKA-II) has been proposed as a potential screening biomarker for HCC. This study was designed to evaluate the role of PIVKA-II as diagnostic HCC marker, and the correlation between PIVKA-II levels and HCC stage. Methods: PIVKA-II levels were assessed on serum samples of Italian patients. The study population included 80 patients with HCC, 111 with liver cirrhosis (LC), and 111 with chronic hepatitis C (CHC). Results: PIVKA-II serum levels progressively increase from patients with CHC to patients with HCC. In the HCC group, PIVKA-II values are higher in the more advanced stages of the disease, assessed by the Barcelona Clinic Liver Cancer (BCLC) staging system (BCLC-B vs. BCLC-A vs. BCLC-0). Youden’s index analysis identified a value >37 mAU/mL as the optimal threshold for the best combination of sensitivity and specificity (80% and 76%, respectively) and, at the best cut-off of 5.2 ng/mL, AFP yielded 53% specificity and 78% sensitivity. The combination of PIVKA-II and AFP reached positive and negative predictive values of 73.9% and 94.2%, respectively. Conclusions: PIVKA-II levels are increased in the HCC patients, compared to control groups. The increase is more evident in patients with advanced HCC. The diagnostic performance of PIVKA-II seems more sensitive than AFP while the combination of PIVKA-II and AFP resulted in the best diagnostic accuracy, reaching 73.9% positive predictive value and 94.2% negative predictive value, thus improving the diagnostic capability of the single marker. Full article
(This article belongs to the Collection Primary Liver Cancer)
18 pages, 391 KiB  
Article
Bridelia ferruginea Tea Consumption Improves Antioxidant Status in Individuals Living with Type 2 Diabetes
by Collins Afriyie Appiah, Jennifer Ngounda, Mavis Boakye-Yiadom, Felix Charles Mills-Robertson, Mariette Nel, Rabia Johnson and Corinna Walsh
Diabetology 2025, 6(1), 6; https://doi.org/10.3390/diabetology6010006 (registering DOI) - 7 Jan 2025
Abstract
Background: It is well-known that persistent hyperglycaemia predisposes individuals with diabetes to oxidative stress. Bridelia ferruginea Benth., a tropical African plant, is known for its antioxidant activity. Methods: This comparative cross-sectional study assessed the oxidative status and associated parameters in 70 individuals living [...] Read more.
Background: It is well-known that persistent hyperglycaemia predisposes individuals with diabetes to oxidative stress. Bridelia ferruginea Benth., a tropical African plant, is known for its antioxidant activity. Methods: This comparative cross-sectional study assessed the oxidative status and associated parameters in 70 individuals living with type 2 diabetes (ILWT2D) who were receiving standard diabetes treatment and consistently drank Bridelia tea (Bridelia group) compared to 92 ILWT2D receiving standard diabetes treatment only (comparator group). Lipid peroxidation assessed using thiobarbituric acid reactive substances (TBARS) served as an indicator of oxidative stress. In addition, the total antioxidant capacity (TAC), glycated haemoglobin (HbA1c), and dietary intake of antioxidant-rich foods were assessed. Results: The comparator group had significantly better glycaemic control [median HbA1c—7.7% (IQR 6.7–9.4)] than the Bridelia group [9.2% (7.6–11.4)], p = 0.001. The comparator group had been on metformin treatment for a significantly longer period than the Bridelia group (p < 0.0001). Participants in the comparator group consumed antioxidant-rich fruits more frequently (monthly basis) than those in the Bridelia group who ate fruits seldomly (p < 0.0001). There was no significant difference (p = 0.11) observed in oxidative stress levels between the Bridelia group and the comparator group [TBARS: 323.0 ng/L (287.5–374.0) and 317.0 ng/L (272.5–342.0), respectively]. Nonetheless, the Bridelia group had significantly higher antioxidant capacity (p = 0.001) compared to the comparator group [TAC: 1.01 mmol/L (0.93–1.10) versus 0.92 mmol/L (0.84–1.03), respectively]. Participants in the comparator group, who did not drink Bridelia tea, had been on longer metformin treatment with better glycaemic control. However, those who drank the Bridelia tea showed comparable levels of oxidative stress and exhibited elevated antioxidant levels compared to those who did not. Conclusion: Bridelia tea consumption may serve as a sustainable source of antioxidants; however, its effect on mitigating oxidative stress in ILWT2D requires further investigation, particularly given that no significant improvement in TBARS was observed. Future studies are needed to clarify the potential role of Bridelia tea in oxidative stress management in resource-limited settings like Ghana. Full article
18 pages, 3250 KiB  
Article
New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment
by Cristina Amaral, Cristina F. Almeida, Maria João Valente, Carla L. Varela, Saul C. Costa, Fernanda M. F. Roleira, Elisiário Tavares-da-Silva, Anne Marie Vinggaard, Natércia Teixeira and Georgina Correia-da-Silva
Cancers 2025, 17(2), 165; https://doi.org/10.3390/cancers17020165 (registering DOI) - 7 Jan 2025
Abstract
Background/Objectives: Endocrine therapies that comprise anti-estrogens and aromatase inhibitors (AIs) are the standard treatment for estrogen receptor-positive (ER+) (Luminal A) breast cancer—the most prevalent subtype. However, the emergence of resistance restricts their success by causing tumor relapse and re-growth, which demands a switch [...] Read more.
Background/Objectives: Endocrine therapies that comprise anti-estrogens and aromatase inhibitors (AIs) are the standard treatment for estrogen receptor-positive (ER+) (Luminal A) breast cancer—the most prevalent subtype. However, the emergence of resistance restricts their success by causing tumor relapse and re-growth, which demands a switch towards other therapeutic approaches in order to minimize or overcome resistance. Indeed, this clinical limitation highlights the search for new molecules to improve cancer treatment. Recently, strategies that address multiple targets have been emerging, and multi-target drugs have the potential to become the future anti-cancer molecules. Our group has been searching for new multi-target compounds, and as part of this, our study aims to understand the anti-cancer and multi-target potential of three new steroidal aromatase inhibitors (AIs): 7α-methylandrost-4-en-17-one (6), 7α-methylandrost-4-ene-3,17-dione (10a) and androsta-4,9(11)-diene-3,17-dione (13). Methods: Their in vitro actions and molecular mechanisms were elucidated in a sensitive ER+ aromatase-overexpressing breast cancer cell line, MCF-7aro cells, as well as in an AI-resistant ER+ breast cancer cell line, LTEDaro cells. Results: All the new AIs (10 µM) prevented the proliferation of MCF-7aro cells by arresting cell cycle progression. Interestingly, all AIs (10 µM) act as androgen receptor (AR) agonists and modulate ER levels, synthesis and signaling to induce the apoptosis of ER+ breast cancer cells. Additionally, these new AIs (10 µM) also re-sensitize resistant cells by promoting apoptosis, offering a therapeutic benefit. Conclusions: Overall, new steroidal polypharmacological compounds have been discovered that, by acting as AIs, ER modulators and AR agonists, impair ER+ breast cancer cell growth. Overall, this study is a breakthrough on drug discovery as it presents new molecules with appealing anti-cancer properties and multi-target action for the treatment of ER+ breast cancer. Full article
(This article belongs to the Collection Innovations in Cancer Drug Development Research)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of the compounds 7α-methylandrost-4-en-17-one (<b>6</b>), 7α-methylandrost-4-ene-3,17-dione (<b>10a</b>) and androsta-4,9(11)-diene-3,17-dione (<b>13</b>).</p>
Full article ">Figure 2
<p>Effects of AIs <b>6</b>, <b>10a</b> and <b>13</b> on the cell viability of the non-tumor cell lines HFF-1 (<b>A</b>) and MCF-10A (<b>B</b>). HFF-1 and MCF-10A cells were incubated with each AI (1–25 μM) over 6 days. Untreated cells representing 100% of cell viability were designated as controls, with the effects of AIs being normalized to these control values.</p>
Full article ">Figure 3
<p>Effects of AIs <b>6</b>, <b>10a</b> and <b>13</b> on the viability of MCF-7aro cells. Cells were treated with T (1 nM) and each AI (1–25 μM) for 3 and 6 days. The actions of each AI were evaluated by MTT (<b>A</b>) and LDH assays (<b>B</b>). Untreated cells representing 100% of cell viability and 1 unit value of LDH release were designated as controls, with data of AIs treatment being normalized to these control values. *** (<span class="html-italic">p</span> &lt; 0.001) denote statistically significant differences between control cells and AI-treated cells.</p>
Full article ">Figure 4
<p>Effects of AIs <b>6</b>, <b>10a</b> and <b>13</b> on MCF-7aro cell death. Cells were incubated with T (1 nM) and with or without each AI at 10 μM for 3 days, in the presence or absence of CDX (1 μM) or ICI (100 nM). Cells without AI treatment were designated as controls, while as a positive control we considered cells incubated with T plus STS (10 µM). The effects on apoptotic cell death were determined by the activation of the effector caspase-7 (<b>A</b>), and data are presented in relative luminescence units (RLUs). The involvement of ERα (<b>B</b>) and AR (<b>C</b>) in the promotion of apoptosis was assessed by caspase-7 activity after incubation of AIs with ICI or CDX, respectively. *** (<span class="html-italic">p</span> &lt; 0.001) denotes statistically significant differences between control cells and AI-treated cells, δδδ (<span class="html-italic">p</span> &lt; 0.001) indicates differences between AI-treated cells in the presence or absence of CDX and ### (<span class="html-italic">p</span> &lt; 0.001) the differences between AI-treated cells in the presence or absence of ICI.</p>
Full article ">Figure 5
<p>The impact of aromatase on the effects exerted by AIs <b>6</b> (<b>A</b>), <b>10a</b> (<b>B</b>) and <b>13</b> (<b>C</b>) on ER<sup>+</sup> breast cancer cells, evaluated by the MTT assay. MCF-7aro cells were incubated with AIs (1, 5 and 10 μM) plus T (1 nM) or E<sub>2</sub> (1 nM) over 3 and 6 days. Untreated cells representing 100% of cell viability were designated as control, being data of AIs normalized to these control values. ** (<span class="html-italic">p</span> &lt; 0.01) indicate significant differences between AI-treated cells incubated with E<sub>2</sub> or with T.</p>
Full article ">Figure 6
<p>The impact of ERα on the effects exerted by AIs <b>6</b>, <b>10a</b> and <b>13</b>. (<b>A</b>) MCF-7aro cell viability effects were determined by MTT assay after treatment over 3 days with T (1 nM) plus AIs (1, 5 and 10 μM) in the presence or absence of ICI (100 nM). (<b>B</b>) ER transactivation assays to explore the effects on ER activation, using VM7Luc4E2 cells incubated with AIs (0.1–10 μM), with (ER antagonism) or without (ER agonism) the hormones T or E<sub>2</sub>. (<b>C</b>) Effects of AIs <b>6</b>, <b>10a</b> and <b>13</b> (10 μM) on ERα protein expression. β-actin was used as a loading control, being data of densitometry represented as ERα/β-actin ratio. (<b>D</b>) Effects of AIs <b>6</b>, <b>10a</b> and <b>13</b> (10 μM) on mRNA transcription of <span class="html-italic">ESR1</span>, <span class="html-italic">TFF1</span>, <span class="html-italic">AREG</span> and <span class="html-italic">EGR3</span> genes in MCF-7aro cells. The mRNA transcript levels of treated cells were quantified using the housekeeping gene <span class="html-italic">ACTB</span>. Cells without treatment were used as control, to which all results in AI-treated cells were normalized. Cells treated with T plus ICI (100 nM) represented positive control. # (<span class="html-italic">p</span> &lt; 0.05), ## (<span class="html-italic">p</span> &lt; 0.01) and ### (<span class="html-italic">p</span> &lt; 0.001) denote differences in MCF-7aro cells treated with AIs in the absence or presence of ICI, while * (<span class="html-italic">p</span> &lt; 0.05), ** (<span class="html-italic">p</span> &lt; 0.01), and *** (<span class="html-italic">p</span> &lt; 0.001) denote differences of AI-treated cells in relation to control cells (T). On the other hand, the differences of AI-treated cells in contrast to control and in relation to ER agonism are indicated by *** (<span class="html-italic">p</span> &lt; 0.001), while in relation to ER antagonism over T are expressed by &amp;&amp;&amp; (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 7
<p>The impact of AR on the effects exerted by AIs <b>6</b>, <b>10a</b> and <b>13</b>. (<b>A</b>) MCF-7aro cell viability effects were determined by MTT assay after treatment, over 3 days, with T (1 nM) plus AIs (1, 5 and 10 μM) in the presence or absence of CDX (1 µM). (<b>B</b>) The AR transactivation assay, AR-EcoScreen™, was used to explore the effects of AIs (0.1–10 μM) with (AR antagonism) or without (AR agonism) R1881 (0.1 nM). (<b>C</b>) Effects of AIs (10 μM) on AR protein expression. β-actin was used as a loading control, being data of densitometry represented as AR/β-actin ratio. Cells without AIs treatment were used as control, to which all results in AI-treated cells were normalized. δ (<span class="html-italic">p</span> &lt; 0.05), δδ (<span class="html-italic">p</span> &lt; 0.01) and δδδ (<span class="html-italic">p</span> &lt; 0.001) denote differences of MCF-7aro cells incubated with AIs in the presence or absence of CDX, while ** (<span class="html-italic">p</span> &lt; 0.01) and *** (<span class="html-italic">p</span> &lt; 0.001) denote differences of AI-treated cells in relation to control cells. On the other hand, the differences of AI-treated cells in contrast to control and in relation to AR agonism, are presented by *** (<span class="html-italic">p</span> &lt; 0.001), whereas in relation to AR antagonism are indicated as &amp; (<span class="html-italic">p</span> &lt; 0.05), &amp;&amp; (<span class="html-italic">p</span> &lt; 0.001) and &amp;&amp;&amp; (<span class="html-italic">p</span> &lt; 0.001).</p>
Full article ">Figure 8
<p>Effects of <b>6</b>, <b>10a</b> and <b>13</b> on AI-resistant ER+ breast cancer cells, LTEDaro. The effects of AIs <b>6</b> (<b>A</b>), <b>10a</b> (<b>B</b>) and <b>13</b> (<b>C</b>) (1–25 μM) on cell viability were determined by the MTT assay after 3 and 6 days. (<b>D</b>) Effects of AIs (10 μM) on cell death after 3 days, by assessing caspase-7 activity. Cells treated only with STS (10 µM) were denominated as positive control. Data are expressed as relative luminescence units (RLUs). Untreated cells were designated as control, to which all results of AI-treated cells were normalized. * (<span class="html-italic">p</span> &lt; 0.05), ** (<span class="html-italic">p</span> &lt; 0.01) and *** (<span class="html-italic">p</span> &lt; 0.001) indicate differences between the control and AI-treated cells.</p>
Full article ">
13 pages, 2914 KiB  
Article
Development of Ketoprofen Impurity A (1-(3-Benzoylphenyl)ethanone) as a Certified Reference Material for Pharmaceutical Quality Control
by Nikolay A. Shulga, Vladimir I. Gegechkori, Natalya V. Gorpinchenko, Valery V. Smirnov, Sergey P. Dementyev and Galina V. Ramenskaya
Pharmaceuticals 2025, 18(1), 59; https://doi.org/10.3390/ph18010059 (registering DOI) - 7 Jan 2025
Abstract
Background/Objectives: Reference materials are essential for ensuring the accuracy and traceability of measurements in the quality control of medicinal products. This study explores new principles for the preparation of impure materials of active pharmaceutical substances, focusing on 1-(3-benzoylphenyl)ethanone ketoprofen impurity A ( [...] Read more.
Background/Objectives: Reference materials are essential for ensuring the accuracy and traceability of measurements in the quality control of medicinal products. This study explores new principles for the preparation of impure materials of active pharmaceutical substances, focusing on 1-(3-benzoylphenyl)ethanone ketoprofen impurity A (European Pharmacopoeia) as the reference material. Methods: The reference material was synthesised from commercially available acetanilide and benzoyl chloride. The obtained product was purified using preparative chromatography and characterised by infrared spectroscopy (IR), 1H and 13C nuclear magnetic resonance (NMR), and mass spectrometry. The structure was verified using primary research methods to confirm its identity as the target product. Results: The characterisation confirmed the structure and purity of 1-(3-benzoylphenyl)ethanone, achieving a purity of 99.86%, meeting regulatory documentation requirements. The synthesised product was demonstrated to be identical to the target compound and suitable for use as a reference material. Conclusions: The developed method provides a robust approach for the preparation and characterisation of 1-(3-benzoylphenyl)ethanone, enabling its use as a certified reference material in the quality control of medicinal products. This approach ensures compliance with regulatory standards and enhances the reliability of pharmaceutical quality assurance practices. Full article
(This article belongs to the Section Pharmaceutical Technology)
Show Figures

Figure 1

Figure 1
<p>Chemical characteristics of ketoprofen impurities (A and C).</p>
Full article ">Figure 2
<p>Scheme of material preparation for 1-(3-benzoylphenyl)ethenone: (<b>a</b>) preparation of 4-acetamidobenzophenone; (<b>b</b>) preparation of 2-acetamido-5-benzoyl-acetophenone; (<b>c</b>) preparation of 2-acetyl-4-benzoylaniline; (<b>d</b>) preparation of 1-(3-benzoylphenyl)ethenone.</p>
Full article ">Figure 3
<p>Chromatogram of crude material 1-(3-benzoylphenyl)ethenone. Blue line: programme gradient; green line: delayed elution gradient.</p>
Full article ">Figure 4
<p>Chromatogram of preparative separation of the crude material 1-(3-benzoylphenyl)ethenone. Blue line: programme gradient; green line: delayed elution gradient; green zone: collection window of the target component fraction.</p>
Full article ">Figure 5
<p>Chromatogram of the purified material 1-(3-benzoylphenyl)ethenone.</p>
Full article ">Figure 6
<p>IR spectra of ketoprofen impurity A material.</p>
Full article ">Figure 7
<p><sup>1</sup>H NMR spectra of ketoprofen impurity A material.</p>
Full article ">Figure 8
<p><sup>13</sup>C NMR spectra of 1-(3-benzoylphenyl)ethenone.</p>
Full article ">Figure 9
<p>Probable fragmentation scheme of 1-(3-benzoylphenyl)ethenone.</p>
Full article ">
22 pages, 1078 KiB  
Article
An Event Causality Identification Framework Using Ensemble Learning
by Xiaoyang Wang, Wenjie Luo and Xiudan Yang
Information 2025, 16(1), 32; https://doi.org/10.3390/info16010032 (registering DOI) - 7 Jan 2025
Abstract
Event causality identification is an upstream operation for many tasks, including knowledge graphs and intelligent question-and-answer systems. The latest models introduce external knowledge and then use deep learning for causality prediction. However, event causality recognition still faces problems such as data imbalance and [...] Read more.
Event causality identification is an upstream operation for many tasks, including knowledge graphs and intelligent question-and-answer systems. The latest models introduce external knowledge and then use deep learning for causality prediction. However, event causality recognition still faces problems such as data imbalance and insufficient event content richness. Additionally, previous frameworks have utilized a single model, but these frequently produce unsatisfactory outcomes such as lower precision rates and lower recall rates. We propose the concept of ensemble learning, which combines multiple models to achieve frameworks that perform as well as or better than the latest models. This framework combines the advantages of Mamba, a temporal convolutional network, and graph computation to identify event causality more effectively and accurately. After comparing our framework to standard datasets, our F1-scores (measures of model accuracy) are essentially the same as those of the state-of-the-art (SOTA) methods on one dataset. Full article
(This article belongs to the Section Artificial Intelligence)
Show Figures

Figure 1

Figure 1
<p>An example taken from the ESL dataset. Events are surrounded by dashed boxes, while events with two-way arrows between them indicate a causal relationship between the two events. Red arrows represent intra-sentence causation and green arrows represent inter-sentence causation.</p>
Full article ">Figure 2
<p>This figure describes in detail how the feature representations of the events are obtained from the sentences, fine-tuned by pre-training, and predicted by the three base models, and finally determined to be causally related or not. The red parts represent the original events, while the green parts represent the knowledge enriched by WordNet and back-translation. When an event consists of multiple tokens, an averaging approach is used to synthesize the features of multiple tokens into the features of a single event. The example in this figure is for inter-sentence causality, but if it is for intra-sentence causality, then the “concat” step is missing.</p>
Full article ">Figure 3
<p>Methods of acquiring external knowledge. The content we introduce to enrich the raw text consists of three parts: the raw event, the synonyms of the first word of the raw event (without special characters), and the reverse translation of the raw event. All three parts are stripped of special characters and are in lower case.</p>
Full article ">Figure 4
<p>Word count in Event Storyline events. The horizontal coordinate represents the number of words in the event, while the vertical coordinate represents how many events have that number of words.</p>
Full article ">Figure 5
<p>Ensemble Learning Framework. This figure shows all models used in our framework. The red parts are fine-tuned pre-trained models. For the final prediction results, only three models, Model<sub>1</sub>, Model<sub>2</sub> and Model<sub>3</sub> are considered. The numbers in brackets represent the input and output dimensions of the hidden layer, while the letters represent the dimension of the current data.</p>
Full article ">Figure 6
<p>Mamba and TCN block. The subgraph (<b>a</b>) on the left is the structure of Mamba and the subgraph (<b>b</b>) on the right is the structure of TCN, where the data flow is from bottom to top.</p>
Full article ">Figure 7
<p>Example of a five-node dual graph. The left side is a dense graph and the right side is its dyadic graph. The decrease in densities at the edges of the dyadic graph makes it easier to focus on the local structure of the graph. The letters in the diagram on the right indicate which vertices connect the two edges.</p>
Full article ">Figure 8
<p>Time complexity analysis. Each graph is labeled with <math display="inline"><semantics> <mrow> <mi>y</mi> <mo>=</mo> <msup> <mi>x</mi> <mn>2</mn> </msup> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mi>y</mi> <mo>=</mo> <msup> <mi>x</mi> <mn>3</mn> </msup> </mrow> </semantics></math> for reference. This makes it easy to see if the MACs vary linearly with batch size or sequence length. There are 50 data points in all four plots, with one data point taken every 10.</p>
Full article ">Figure 9
<p>Space complexity analysis. As with the time complexity analysis, 50 data points were taken, with the only difference being the choice of batch size, both of which max out at 4901. Although the change in the lines is not strictly linear, the fit appears to change linearly.</p>
Full article ">Figure 9 Cont.
<p>Space complexity analysis. As with the time complexity analysis, 50 data points were taken, with the only difference being the choice of batch size, both of which max out at 4901. Although the change in the lines is not strictly linear, the fit appears to change linearly.</p>
Full article ">Figure 10
<p>The effect of the values of <math display="inline"><semantics> <mrow> <mi>v</mi> <msub> <mi>w</mi> <mn>1</mn> </msub> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>v</mi> <msub> <mi>w</mi> <mn>2</mn> </msub> </mrow> </semantics></math> and <math display="inline"><semantics> <mrow> <mi>v</mi> <msub> <mi>w</mi> <mn>3</mn> </msub> </mrow> </semantics></math> on F1. The four plots are categorized as ESL intra-sentence causality, ESL inter-sentence causality, ESL all causality, and CTB intra-sentence causality. We plotted the 3D scatterplots by adjusting the scale of vw<sub><span class="html-italic">c</span></sub> to keep the sum at 4, and then computing the corresponding F1-scores separately. Red areas indicate superior performance and green areas indicate poor performance.</p>
Full article ">Figure 11
<p>Hyper-parameter sensitivity analysis. We perform sensitivity tests on the two most frequently changed parameters, learning rate and epoch, for each of the three models, DistilBERT fine-tuning, Model<sub>1</sub> and Model<sub>2</sub>. The vertical coordinate is the reference F1-score and the horizontal coordinate is the hyper-parameter.</p>
Full article ">Figure 12
<p>The objective of this experimental procedure is to ascertain the impact of the kNN parameter n on F1-scores.</p>
Full article ">
16 pages, 1445 KiB  
Article
Identification of Bacillus anthracis Strains from Animal Cases in Ethiopia and Genetic Characterization by Whole-Genome Sequencing
by Abebe Olani, Domenico Galante, Matios Lakew, Bayeta Senbeta Wakjira, Getnet Abie Mekonnen, Tesfaye Rufael, Tsegaye Teklemariam, Wondwosen Kumilachew, Shimalis Dejene, Ayele Woldemeskel, Adanech Wakjira, Getachew Abichu, Baye Ashenafi, Nigatu Kebede, Aklilu Feleke Haile, Fufa Dawo Bari, Laura Del Sambro and Tadesse Eguale
Pathogens 2025, 14(1), 39; https://doi.org/10.3390/pathogens14010039 (registering DOI) - 7 Jan 2025
Abstract
Anthrax is a zoonotic disease characterized by rapid onset with usual fatal outcomes in livestock and wildlife. In Ethiopia, anthrax is a persistent disease; however, there are limited data on the isolation and molecular characterization of Bacillus anthracis strains. This study aimed to [...] Read more.
Anthrax is a zoonotic disease characterized by rapid onset with usual fatal outcomes in livestock and wildlife. In Ethiopia, anthrax is a persistent disease; however, there are limited data on the isolation and molecular characterization of Bacillus anthracis strains. This study aimed to characterize B. anthracis isolated from animal anthrax outbreaks between 2019 and 2024, from different localities in Ethiopia. B. anthracis was identified using standard microbiology techniques and confirmed by real-time PCR. For the first time in Ethiopia, the genetic diversity of five Bacillus anthracis strains, isolated from dead cattle and goats, was investigated by Whole Genome Sequencing (WGS) and bioinformatics analyses. The five sequenced strains were compared to one Ethiopian B. anthracis genome and the other 29 B. anthracis genomes available in the global genetic databases to determine their phylogeny. The genomes of the strains were also analyzed to detect the presence of antimicrobial resistance and virulence genes. The whole genome SNP analysis showed that the Ethiopian B. anthracis strains were grouped in the A clade. Three strains (BA2, BA5, and BA6) belonged to the A.Br.034 subgroup (A.Br.005/006), and two strains (BA1 and BA4) belonged to the A.Br.161 (Heroin) clade of the Trans-Eurasian (TEA) group. The findings of this study will contribute to expanding the current understanding of the anthrax hotspots in Ethiopia, and the phylogenetic correlation and/or diversity of the circulating strains. Full article
(This article belongs to the Special Issue Current Research on Bacillus anthracis Infection)
Show Figures

Figure 1

Figure 1
<p>Map of Ethiopia showing the sites where <span class="html-italic">B. anthracis</span> strains were isolated.</p>
Full article ">Figure 2
<p>Ox dead of anthrax showing bloody discharge from the anus in Bonga Town (<b>A</b>); burying of a cow dead of anthrax in Deber Work Town, 2023 (<b>B</b>); bones collected following the death of a cow in Ada Berga District (<b>C</b>).</p>
Full article ">Figure 3
<p>Evidence of Gram-positive, thick long chains of bacilli (<b>A</b>); evidence of <span class="html-italic">B. anthracis</span> spores (in green) by malachite green staining (<b>B</b>); evidence of capsule pinkish-red stained, and bacilli blue stained by Giemsa staining (<b>C</b>).</p>
Full article ">Figure 4
<p>(<b>A</b>) Global phylogeny of 35 <span class="html-italic">B. anthracis</span> strains generated using the SNP Phylogeny (Samtools) Pipeline, with strains grouped by CanSNP classifications as defined [<a href="#B18-pathogens-14-00039" class="html-bibr">18</a>]; (<b>B</b>) Phylogenetic tree of representatives from the A.Br.034 (Ancient A) CanSNP group, and (<b>C</b>) Phylogenetic tree of representatives from the A.Br.161 (Heroin) CanSNP group. The reference genome used was ‘Ames Ancestor’ (NC_007530.2). Colored tips indicate CanSNP group nicknames, while empty circles represent strains that have not yet been assigned to a genetic group.</p>
Full article ">
16 pages, 4995 KiB  
Article
Reliability of a Low-Cost Inertial Measurement Unit (IMU) to Measure Punch and Kick Velocity
by Lukas Pezenka and Klaus Wirth
Sensors 2025, 25(2), 307; https://doi.org/10.3390/s25020307 (registering DOI) - 7 Jan 2025
Abstract
Striking velocity is a key performance indicator in striking-based combat sports, such as boxing, Karate, and Taekwondo. This study aims to develop a low-cost, accelerometer-based system to measure kick and punch velocities in combat athletes. Utilizing a low-cost mobile phone in conjunction with [...] Read more.
Striking velocity is a key performance indicator in striking-based combat sports, such as boxing, Karate, and Taekwondo. This study aims to develop a low-cost, accelerometer-based system to measure kick and punch velocities in combat athletes. Utilizing a low-cost mobile phone in conjunction with the PhyPhox app, acceleration data was collected and analyzed using a custom algorithm. This involved strike segmentation and numerical integration to determine velocity. The system demonstrated moderate reliability (intraclass correlation coefficient (ICC) 3,1 = 0.746 to 0.786, standard error of measurement (SEM) = 0.488 to 0.921 m/s), comparable to commercially available systems. Biological and technical variations, as well as test standardization issues, were acknowledged as factors influencing reliability. Despite a relatively low sampling frequency, the hardware and software showed potential for reliable measurement. The study highlights the importance of considering within-subject variability, hardware limitations, and the impact of noise in software algorithms. Average strike velocities exhibited higher reliability than peak velocities, making them a practical choice for performance tracking, although they may underestimate true peak performance. Future research should validate the system against gold-standard methods and determine the optimal sampling frequency to enhance measurement accuracy. Full article
(This article belongs to the Collection Sensor Technology for Sports Science)
Show Figures

Figure 1

Figure 1
<p>Methodological approach to velocity calculation. Data are collected during the field test and then segmented and evaluated in a post-processing step. CSV: comma separated file, s: second.</p>
Full article ">Figure 2
<p>Strike segmentation and velocity calculation. m: meter, s: second, ms: millisecond, a: acceleration, xyz: respective axis of motion, aabs: absolute acceleration (<math display="inline"><semantics> <msqrt> <mrow> <msubsup> <mi>a</mi> <mi>x</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>a</mi> <mi>y</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>a</mi> <mi>z</mi> <mn>2</mn> </msubsup> </mrow> </msqrt> </semantics></math>), v: velocity, vabs: absolute velocity (<math display="inline"><semantics> <msqrt> <mrow> <msubsup> <mi>v</mi> <mi>x</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>v</mi> <mi>y</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>v</mi> <mi>z</mi> <mn>2</mn> </msubsup> </mrow> </msqrt> </semantics></math>). (<b>a</b>) Acceleration profiles of five punches; (<b>b</b>) segmented punch (600 ms around peak acceleration); (<b>c</b>) initiation to contact; (<b>d</b>) velocity integration.</p>
Full article ">Figure 2 Cont.
<p>Strike segmentation and velocity calculation. m: meter, s: second, ms: millisecond, a: acceleration, xyz: respective axis of motion, aabs: absolute acceleration (<math display="inline"><semantics> <msqrt> <mrow> <msubsup> <mi>a</mi> <mi>x</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>a</mi> <mi>y</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>a</mi> <mi>z</mi> <mn>2</mn> </msubsup> </mrow> </msqrt> </semantics></math>), v: velocity, vabs: absolute velocity (<math display="inline"><semantics> <msqrt> <mrow> <msubsup> <mi>v</mi> <mi>x</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>v</mi> <mi>y</mi> <mn>2</mn> </msubsup> <mo>+</mo> <msubsup> <mi>v</mi> <mi>z</mi> <mn>2</mn> </msubsup> </mrow> </msqrt> </semantics></math>). (<b>a</b>) Acceleration profiles of five punches; (<b>b</b>) segmented punch (600 ms around peak acceleration); (<b>c</b>) initiation to contact; (<b>d</b>) velocity integration.</p>
Full article ">Figure 3
<p>Data collection during the jab punch. (<b>a</b>) Guard position; smartphone with IMU attached to the distal wrist; (<b>b</b>) execution phase.</p>
Full article ">Figure 4
<p>Data collection during the lead roundhouse kick. (<b>a</b>) Guard position; smartphone with IMU attached to the distal calf; (<b>b</b>) chamber phase; (<b>c</b>) extension phase.</p>
Full article ">Figure 5
<p>Bland–Altman plot for punch and kick velocities (in m/s). Dashed lines indicate the 95% LOAs, which were set to ±1.96 standard deviations, following the guidelines by Atkinson and Nevill [<a href="#B32-sensors-25-00307" class="html-bibr">32</a>].</p>
Full article ">
18 pages, 2321 KiB  
Article
Communication and Sensing: Wireless PHY-Layer Threats to Security and Privacy for IoT Systems and Possible Countermeasures
by Renato Lo Cigno, Francesco Gringoli, Stefania Bartoletti, Marco Cominelli, Lorenzo Ghiro and Samuele Zanini
Information 2025, 16(1), 31; https://doi.org/10.3390/info16010031 (registering DOI) - 7 Jan 2025
Abstract
Recent advances in signal processing and AI-based inference enable the exploitation of wireless communication signals to collect information on devices, people, actions, and the environment in general, i.e., to perform Integrated Sensing And Communication (ISAC). This possibility offers exciting opportunities for Internet of [...] Read more.
Recent advances in signal processing and AI-based inference enable the exploitation of wireless communication signals to collect information on devices, people, actions, and the environment in general, i.e., to perform Integrated Sensing And Communication (ISAC). This possibility offers exciting opportunities for Internet of Things (IoT) systems, but it also introduces unprecedented threats to the security and privacy of data, devices, and systems. In fact, ISAC operates in the wireless PHY and Medium Access Control (MAC) layers, where it is impossible to protect information with standard encryption techniques or with any other purely digital methodologies. The goals of this paper are threefold. First, it analyzes the threats to security and privacy posed by ISAC and how they intertwine in the wireless PHY layer within the framework of IoT and distributed pervasive communication systems in general. Secondly, it presents and discusses possible countermeasures to protect users’ security and privacy. Thirdly, it introduces an architectural proposal, discussing the available choices and tradeoffs to implement such countermeasures, as well as solutions and protocols to preserve the potential benefits of ISAC while ensuring data protection and users’ privacy. The outcome and contribution of the paper is a systematic argumentation on wireless PHY-layer privacy and security threats and their relation with ISAC, framing the boundaries that research and innovation in this area should respect to avoid jeopardizing people’s rights. Full article
(This article belongs to the Special Issue Data Privacy Protection in the Internet of Things)
17 pages, 630 KiB  
Article
Evidence Gaps and Lessons in the Early Detection of Atrial Fibrillation: A Prospective Study in a Primary Care Setting (PREFATE Study)
by Josep L. Clua-Espuny, Alba Hernández-Pinilla, Delicia Gentille-Lorente, Eulàlia Muria-Subirats, Teresa Forcadell-Arenas, Cinta de Diego-Cabanes, Domingo Ribas-Seguí, Anna Diaz-Vilarasau, Cristina Molins-Rojas, Meritxell Palleja-Millan, Eva M. Satué-Gracia and Francisco Martín-Luján
Biomedicines 2025, 13(1), 119; https://doi.org/10.3390/biomedicines13010119 (registering DOI) - 7 Jan 2025
Abstract
Background/Objectives: In Europe, the prevalence of AF is expected to increase 2.5-fold over the next 50 years with a lifetime risk of 1 in 3–5 individuals after the age of 55 years and a 34% rise in AF-related strokes. The PREFATE project investigates [...] Read more.
Background/Objectives: In Europe, the prevalence of AF is expected to increase 2.5-fold over the next 50 years with a lifetime risk of 1 in 3–5 individuals after the age of 55 years and a 34% rise in AF-related strokes. The PREFATE project investigates evidence gaps in the early detection of atrial fibrillation in high-risk populations within primary care. This study aims to estimate the prevalence of device-detected atrial fibrillation (DDAF) and assess the feasibility and impact of systematic screening in routine primary care. Methods: The prospective cohort study (NCT 05772806) included 149 patients aged 65–85 years, identified as high-risk for AF. Participants underwent 14 days of cardiac rhythm monitoring using the Fibricheck® app (CE certificate number BE16/819942412), alongside evaluations with standard ECG and transthoracic echocardiography. The primary endpoint was a new AF diagnosis confirmed by ECG or Holter monitoring. Statistical analyses examined relationships between AF and clinical, echocardiographic, and biomarker variables. Results: A total of 18 cases (12.08%) were identified as positive for possible DDAF using FibriCheck® and 13 new cases of AF were diagnosed during follow-up, with a 71.4-fold higher probability of confirming AF in FibriCheck®-positive individuals than in FibriCheck®-negative individuals, resulting in a post-test odds of 87.7%. Significant echocardiographic markers of AF included reduced left atrial strain (<26%) and left atrial ejection fraction (<50%). MVP ECG risk scores ≥ 4 strongly predicted new AF diagnoses. However, inconsistencies in monitoring outcomes and limitations in current guidelines, particularly regarding AF burden, were observed. Conclusions: The study underscores the feasibility and utility of AF screening in primary care but identifies critical gaps in diagnostic criteria, anticoagulation thresholds, and guideline recommendations. Full article
(This article belongs to the Special Issue Feature Reviews in Cardiovascular Diseases)
Show Figures

Figure 1

Figure 1
<p>CONSORT (2010) diagram adapted for this study: Screening and follow-up of the study participants. AF: atrial fibrillation; AHREs: atrial high-rate episodes; DDAF: device-detected atrial fibrillation; ECG: electrocardiogram.</p>
Full article ">
5 pages, 177 KiB  
Proceeding Paper
Research on the Requirement Validation Process of an eVTOL Aircraft
by Haiyun Yang, Yiheng Li and Jing Hu
Eng. Proc. 2024, 80(1), 16; https://doi.org/10.3390/engproc2024080016 (registering DOI) - 7 Jan 2025
Abstract
According to the SAEARP4754B standard, the positive development of electric vertical takeoff and landing (eVTOL) aircraft must carry out requirement management in order to ensure the traceability of requirements. The requirement validation process plays a key role in the requirement traceability process, and [...] Read more.
According to the SAEARP4754B standard, the positive development of electric vertical takeoff and landing (eVTOL) aircraft must carry out requirement management in order to ensure the traceability of requirements. The requirement validation process plays a key role in the requirement traceability process, and this paper is mainly about the research on the requirement validation process. The steps of optimizing the requirement validation process are to formulate validation plans, define the initial validation matrix template, select the validation approach, implement requirement validation, and notify the relevant parties of the problems found in validation. The implementation of the optimized requirement validation process avoids human error to some extent. Full article
(This article belongs to the Proceedings of 2nd International Conference on Green Aviation (ICGA 2024))
29 pages, 5224 KiB  
Article
Optimization of the Antibacterial Activity of a Three-Component Essential Oil Mixture from Moroccan Thymus satureioides, Lavandula angustifolia, and Origanum majorana Using a Simplex–Centroid Design
by Amine Elbouzidi, Mohamed Taibi, Naoufal El Hachlafi, Mounir Haddou, Mohamed Jeddi, Abdellah Baraich, Saad Bougrine, Ramzi A. Mothana, Mohammed F. Hawwal, Waleed A. Alobaid, Abdeslam Asehraou, Bouchra El Guerrouj, Hanae Naceiri Mrabti, Francois Mesnard and Mohamed Addi
Pharmaceuticals 2025, 18(1), 57; https://doi.org/10.3390/ph18010057 (registering DOI) - 7 Jan 2025
Abstract
Background/Objectives: The rise of antibiotic-resistant pathogens has become a global health crisis, necessitating the development of alternative antimicrobial strategies. This study aimed to optimize the antibacterial effects of essential oils (EOs) from Thymus satureioides, Lavandula angustifolia, and Origanum majorana, enhancing their [...] Read more.
Background/Objectives: The rise of antibiotic-resistant pathogens has become a global health crisis, necessitating the development of alternative antimicrobial strategies. This study aimed to optimize the antibacterial effects of essential oils (EOs) from Thymus satureioides, Lavandula angustifolia, and Origanum majorana, enhancing their efficacy through optimized mixtures. Methods: This study utilized a simplex–centroid design to optimize the mixture ratios of EOs for maximal antibacterial and antioxidant effectiveness. The chemical profiles of the EOs were analyzed using gas chromatography-mass spectrometry (GC-MS). The antibacterial activity was assessed against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa using minimum inhibitory concentration (MIC) tests, while antioxidant activity was evaluated through DPPH (2,2-diphenyl-1-picrylhydrazyl), and ABTS (2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) assays. Results: The optimized essential oil mixtures demonstrated potent antibacterial activity, with MIC values of 0.097% (v/v) for E. coli, 0.058% (v/v) for S. aureus, and 0.250% (v/v) for P. aeruginosa. The mixture ratios achieving these results included 76% T. satureioides, and 24% O. majorana for E. coli, and varying proportions for other strains. Additionally, L. angustifolia essential oil exhibited the strongest antioxidant activity, with IC50 values of 84.36 µg/mL (DPPH), and 139.61 µg/mL (ABTS), surpassing both the other EOs and standard antioxidants like BHT and ascorbic acid in the ABTS assay. Conclusions: The study successfully demonstrates that optimized mixtures of EOs can serve as effective natural antibacterial agents. The findings highlight a novel approach to enhance the applications of essential oils, suggesting their potential use in food preservation and biopharmaceutical formulations. This optimization strategy offers a promising avenue to combat antibiotic resistance and enhance food safety using natural products. Full article
(This article belongs to the Section Natural Products)
Show Figures

Figure 1

Figure 1
<p>Chemical diversity of sub-classes of terpenes found in the studied essential oils from <span class="html-italic">T. satureioides</span>, <span class="html-italic">L. angustifolia</span>, and <span class="html-italic">O. majorana</span>.</p>
Full article ">Figure 2
<p>The antioxidant activity of the EOs was assessed using the DPPH assay (<b>A</b>) and the ABTS test (<b>B</b>), with butylated hydroxytoluene (BHT) and ascorbic acid (AA) serving as reference standards. Results are expressed as the mean ± standard deviation (SD) from three independent experiments. Statistically significant differences between groups are denoted by different letters, with significance established at <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 3
<p>MIC responses against <span class="html-italic">E. coli</span>, <span class="html-italic">S. aureus</span>, and <span class="html-italic">P. aeruginosa</span> are represented by curves illustrating the relationship between the experimental values and the expected values, depicted by red lines. Meanwhile, the blue lines indicate the actual mean values for the two responses under investigation.</p>
Full article ">Figure 4
<p>The optimal MIC value for <span class="html-italic">E. coli</span> was determined through an in-depth analysis of 2D and 3D mixture plots, focusing on the identified compromise zone. Panels (<b>a</b>,<b>b</b>) display 3D mixture plots that highlight the desired compromise region, located within the binary mixing zone between <span class="html-italic">T. satureioides</span> and <span class="html-italic">O. majorana</span>. This zone represents the optimal conditions for achieving maximum antibacterial activity. Panel (<b>c</b>) further illustrates this relationship through a 2D mixture plot, pinpointing the specific proportions of the EOs required to reach the desired MIC value of 0.097% against the <span class="html-italic">E. coli</span> strain. The optimal composition was achieved with a mixture consisting of 76% <span class="html-italic">T. satureioides</span>, and 24% <span class="html-italic">O. majorana</span> EOs. EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 5
<p>Desirability profile illustrating the precise proportions, leading to the optimum value for MIC<span class="html-italic"><sub>E.coli</sub>.</span> EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 6
<p>The optimal MIC value for <span class="html-italic">S. aureus</span> was determined through an analysis of 2D and 3D mixture plots focused on the identified compromise region. Panels (<b>a</b>,<b>b</b>) illustrate 3D mixture plots, highlighting the desired compromise zone within the ternary mixing area of <span class="html-italic">T. satureioides</span>, <span class="html-italic">L. angustifolia</span>, and <span class="html-italic">O. majorana</span>. Panel (<b>c</b>) presents a 2D mixture plot, which identifies the optimal compromise region leading to the desired MIC value of 0.058% against <span class="html-italic">S. aureus</span>. This result was achieved by using a ternary mixture composed of 61% <span class="html-italic">T. satureioides</span>, 29% <span class="html-italic">L. angustifolia</span>, and 10% <span class="html-italic">O. majorana</span> essential oils. EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 7
<p>Desirability profile illustrating the precise proportions leading to the optimum value for MIC<span class="html-italic"><sub>S.aureus</sub></span>. EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 8
<p>The optimal MIC value for <span class="html-italic">P. aeruginosa</span> was determined through an analysis of 2D and 3D mixture plots focused on the identified compromise region. Panels (<b>a</b>,<b>b</b>) depict 3D mixture plots, highlighting the desired compromise zone within the binary mixing area of <span class="html-italic">T. satureioides</span> and <span class="html-italic">O. majorana</span>. Panel (<b>c</b>) presents a 2D mixture plot that identifies the optimal compromise region, achieving the target MIC value of 0.25% against <span class="html-italic">P. aeruginosa</span>. This result was attained with a binary mixture comprising 81% <span class="html-italic">T. satureioides</span> and 19% <span class="html-italic">O. majorana</span> essential oils. EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 9
<p>Desirability profile illustrating the precise proportions leading to the optimum value for MIC<span class="html-italic"><sub>P. aeruginosa</sub></span>. EO1: <span class="html-italic">T. satureioides</span> EO; EO2: <span class="html-italic">L. angustifolia</span> EO; EO3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">Figure 10
<p>2D mixture contour plot of the optimal combination region between EOs, resulting in the best value of MIC for <span class="html-italic">E. coli</span>, <span class="html-italic">S. aureus</span>, and <span class="html-italic">P. aeruginosa</span>.</p>
Full article ">Figure 11
<p>EDesirability profiles of the simultaneous optimization of all responses yielding an optimal mixture of 76% of EO1 (<span class="html-italic">T. satureioides</span>), 0% EO2 (<span class="html-italic">L. angustifolia</span>), and 24% of EO3 (<span class="html-italic">O. majorana</span>).</p>
Full article ">Figure 12
<p>Equilateral triangle of the arrangement of mixtures using the simplex centroid design method. H1: <span class="html-italic">T. satureioides</span> EO; H2: <span class="html-italic">L. angustifolia</span> EO; H3: <span class="html-italic">O. majorana</span> EO.</p>
Full article ">
Back to TopTop